Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the analgesic effect of oral potassium diclofenac
in patients with proliferative diabetic retinopathy submitted to retinal photocoagulation.
Two groups of patients were followed and the effect of the treatment (diclofenac plus laser)
was compared to placebo (placebo plus laser). Pain associated with treatment was recorded
using a Visual Analog Scale 15 minutes after the procedure.